Waters launched its Apple iPad application at the recent HPLC conference that took place last month in Budapest, Hungary. The app will allow customers to choose the most appropriate sample plates, vials and filters at the touch of the screen.
Waters launched its Apple iPad application at the recent HPLC conference that took place last month in Budapest, Hungary. The app will allow customers to choose the most appropriate sample plates, vials and filters at the touch of the screen.
Commenting on this move into mobile communication technology, Dr Mark Baynham, director, channel management at Waters, said, "Many of our customers are extending the use of mobile devices into their professional lives, including laboratory management. For those customers, we have approached the development of our iPad app with the same level of understanding and commitment to innovation that Waters brings to all product development. The initial app has been designed specifically for the iPad platform and sets the stage for future innovative tools designed for lab scientists."
Developed in collaboration with Roundarch, a leader in digital design and development for the world’s largest organizations, the architecture allows for future expansion and updates without needing to install a new version of the app.
The Waters iPad app is available for download at the iTunes App Store
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.